Healthcare

Medline is a large healthcare supplies platform with recurring demand, broad customer reach, and growing scale. Stronger revenue and cash generation have improved the operating picture, while margin progress and lower financing pressure could shape the next stage of its profile.

Labcorp is a major diagnostics and biopharma laboratory company with national scale, recurring healthcare demand, and expanding specialty testing exposure. Recent results show a business rebuilding margins and cash flow after the post-COVID reset.

Incyte is a profitable biotech company built on a leading hematology franchise and a growing mix of newer medicines. Strong cash flow, very low debt, and faster-than-sector growth make it a compelling case to examine for long-term business quality.

Insmed is building on ARIKAYCE sales while preparing a potentially much larger growth phase led by brensocatib and other lung-disease programs. The company combines a real commercial base with high-impact pipeline potential in areas of serious unmet need.

IQVIA combines clinical research, healthcare data, and software in a platform tied to long-term pharmaceutical demand. Steady revenue growth, strong margins, and rising cash flow make it a compelling business to examine more closely.

IDEXX Laboratories supplies diagnostic tools, lab services, and software mainly for veterinary clinics. Its appeal comes from recurring revenue, strong margins, and growing cash generation, supported by a leading position in companion animal healthcare.

Illumina provides the tools behind modern DNA sequencing, with a large installed base and recurring consumables revenue. As revenue growth and cash flow recover, the company again stands out as a central genomics platform worth examining in depth.